Statistics Collaborative - Design and analysis for biomedical research


Amy Tillman, M.S.
Senior Biostatistician

Amy Tillman, M.S., joined Statistics Collaborative, Inc. (SCI) in 2013. She is a member of the American Statistical Association, the Washington Statistical Society, and Mu Sigma Rho, the National Statistics Honor Society.

At SCI, Ms. Tillman has contributed to clinical trials in a number of areas, including neurodegenerative diseases, inherited retinal diseases, soft-tissue sarcoma, renal cell carcinoma, type 2 diabetes, HIV, malaria, gonorrhea, growth hormone deficiency, and Alzheimer’s disease.

Ms. Tillman prepares and audits CDISC-compliant ADaM datasets and documentation. She coordinated and managed programming efforts for a final statistical analysis, prepared ADRGs for FDA submission, and performed analyses for the FDA and EMA at request. At the FDA Advisory Committee for inherited retinal diseases caused by mutations in the RPE65 gene, Ms. Tillman was the statistical back-room lead.

She has also been involved in SCI’s role as Scientific Secretariat for an expert panel discussing novel approaches to vaccine development. At SCI, she serves on the committee to develop best practices for programming and validation in R.

She received her B.S. cum laude in Mathematics with a minor in Statistics from the University of Georgia (2010) and her M.S. in Statistics with a quantitative certificate in Fisheries Science from Virginia Polytechnic Institute and State University (2012).